This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Reprints and Permissions Copyright Information Books from ASM Press MicrobeWorld Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Rukavina, T. Articles by Trautmann, M. Search for Related Content PubMed PubMed Citation Articles by Rukavina, T. Articles by Trautmann, M.

 Previous Article  |  Next Article 

Infect. Immun., May 1997, 1754-1760, Vol 65, No. 5
Copyright © 1997, American Society for Microbiology

Protective effect of antilipopolysaccharide monoclonal antibody in experimental Klebsiella infection

T Rukavina, B Ticac, M Susa, N Jendrike, S Jonjic, P Lucin, R Marre, M Doric and M Trautmann
Department of Microbiology and Parasitology, University of Rijeka, Croatia.

An O-antigen-specific murine monoclonal antibody (MAb) directed against an immunodominant epitope expressed on Klebsiella O1, O6, and O8 lipopolysaccharides (LPS) was examined with respect to its binding to nonencapsulated and encapsulated bacterial cells and its ability to protect against lethal murine Klebsiella sepsis. While the MAb (clone Ru-O1, mouse immunoglobulin G2b) bound well to nonencapsulated organisms of the O1 serogroup, binding was significantly, but not completely, abolished by the presence of the K2 capsule. In a model of experimental Klebsiella peritonitis and sepsis induced by a virulent O1:K2 serogroup strain, higher doses of anti-LPS MAb Ru-O1 than of a previously described anticapsular MAb specific for the K2 capsular polysaccharide were needed to provide protection. However, high-dose (40 microg/g of body weight) pretreatment with anti-LPS MAb Ru-O1 significantly reduced bacterial dissemination to various organs as well as macroscopic and histologic pulmonary alterations. Thus, since the number of Klebsiella capsular antigens occurring in clinical material is too large to be completely "covered" by a K-antigen-specific hyperimmunoglobulin preparation, O-antigen-specific antibodies may supplement K-antigen-specific immunoprophylaxis and -therapy of clinical Klebsiella infection.

This article has been cited by other articles:

• Brade, L., Podschun, R., Brade, H. (2001). A monoclonal antibody with specificity for the genus Klebsiella binds to a common epitope located in the core region of Klebsiella lipopolysaccharide. Innate Immunity 7: 119-124 [Abstract]  
• Held, T. K., Jendrike, N. R. M., Rukavina, T., Podschun, R., Trautmann, M. (2000). Binding to and Opsonophagocytic Activity of O-Antigen-Specific Monoclonal Antibodies against Encapsulated and Nonencapsulated Klebsiella pneumoniae Serotype O1 Strains. Infect. Immun. 68: 2402-2409 [Abstract] [Full Text]  
• Hansen, D. S., Mestre, F., Albertí, S., Hernández-Allés, S., Álvarez, D., Doménech-Sánchez, A., Gil, J., Merino, S., Tomás, J. M., Benedí, V. J. (1999). Klebsiella pneumoniae Lipopolysaccharide O Typing: Revision of Prototype Strains and O-Group Distribution among Clinical Isolates from Different Sources and Countries. J. Clin. Microbiol. 37: 56-62 [Abstract] [Full Text]